Oyama K, Ueda T
PLoS One. 2024; 19(7):e0307320.
PMID: 39038003
PMC: 11262634.
DOI: 10.1371/journal.pone.0307320.
Li W, Wei J, Jiang Q, Zhou Y, Yan X, Xiang C
Curr Med Chem. 2024; 31(26):4100-4110.
PMID: 38275064
DOI: 10.2174/0109298673264899231206093930.
Nielsen M, Andreatta M, Peters B, Buus S
Annu Rev Biomed Data Sci. 2023; 3:191-215.
PMID: 37427310
PMC: 10328453.
DOI: 10.1146/annurev-biodatasci-021920-100259.
Yu X, Negron C, Huang L, Veldman G
Antib Ther. 2023; 6(2):137-146.
PMID: 37342671
PMC: 10278228.
DOI: 10.1093/abt/tbad011.
Jiang N, Malone M, Chizari S
Immunol Rev. 2023; 316(1):120-135.
PMID: 37209375
PMC: 10524458.
DOI: 10.1111/imr.13217.
Know thy immune self and non-self: Proteomics informs on the expanse of self and non-self, and how and where they arise.
Joyce S, Ternette N
Proteomics. 2021; 21(23-24):e2000143.
PMID: 34310018
PMC: 8865197.
DOI: 10.1002/pmic.202000143.
Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions.
Paul S, Grifoni A, Peters B, Sette A
Front Immunol. 2020; 10:3151.
PMID: 32117208
PMC: 7012937.
DOI: 10.3389/fimmu.2019.03151.
A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.
Watanabe N, Suzuki Y, Yonezu T, Nakagawa Y, Shiina T, Hirayama N
Sci Rep. 2017; 7(1):6798.
PMID: 28754892
PMC: 5533769.
DOI: 10.1038/s41598-017-07080-4.
The Affinity of Elongated Membrane-Tethered Ligands Determines Potency of T Cell Receptor Triggering.
Chen B, Al-Aghbar M, Lee C, Chang T, Su Y, Li Y
Front Immunol. 2017; 8:793.
PMID: 28740495
PMC: 5502409.
DOI: 10.3389/fimmu.2017.00793.
Class II major histocompatibility complex mutant mice to study the germ-line bias of T-cell antigen receptors.
Silberman D, Krovi S, Tuttle K, Crooks J, Reisdorph R, White J
Proc Natl Acad Sci U S A. 2016; 113(38):E5608-17.
PMID: 27588903
PMC: 5035841.
DOI: 10.1073/pnas.1609717113.
Multivalent Antigens for Promoting B and T Cell Activation.
Bennett N, Zwick D, Courtney A, Kiessling L
ACS Chem Biol. 2015; 10(8):1817-24.
PMID: 25970017
PMC: 4669068.
DOI: 10.1021/acschembio.5b00239.
Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration.
Tobin R, Mukherjee S, Kain J, Rogers S, Henderson S, Motal H
Acta Neuropathol Commun. 2014; 2:143.
PMID: 25329434
PMC: 4203873.
DOI: 10.1186/s40478-014-0143-5.
Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.
Sidney J, Southwood S, Moore C, Oseroff C, Pinilla C, Grey H
Curr Protoc Immunol. 2013; Chapter 18:Unit 18.3..
PMID: 23392640
PMC: 3626435.
DOI: 10.1002/0471142735.im1803s100.
Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
Dolan B, Bennink J, Yewdell J
Cell Mol Life Sci. 2011; 68(9):1481-9.
PMID: 21416150
PMC: 3393103.
DOI: 10.1007/s00018-011-0656-z.
MHC class II epitope predictive algorithms.
Nielsen M, Lund O, Buus S, Lundegaard C
Immunology. 2010; 130(3):319-28.
PMID: 20408898
PMC: 2913211.
DOI: 10.1111/j.1365-2567.2010.03268.x.
Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.
Sadegh-Nasseri S, Natarajan S, Chou C, Hartman I, Narayan K, Kim A
Immunol Res. 2010; 47(1-3):56-64.
PMID: 20066513
PMC: 3075107.
DOI: 10.1007/s12026-009-8138-1.
The T-cell response to haptenated insulins. I. The proliferative response.
Wallace G, Briffa J, McCafferty I, Askenase P, Chain B
Immunology. 1989; 66(1):39-44.
PMID: 15493260
PMC: 1385117.
Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease.
Oshitani N, Hato F, Jinno Y, Sawa Y, Hara J, Nakamura S
Dig Dis Sci. 2002; 47(9):2088-94.
PMID: 12353860
DOI: 10.1023/a:1019689332601.
HLA-DM and the MHC class II antigen presentation pathway.
Jensen P, Weber D, Thayer W, Chen X, Dao C
Immunol Res. 2000; 20(3):195-205.
PMID: 10741860
DOI: 10.1007/BF02790403.
Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405).
Senpuku H, Yanagi K, Nisizawa T
Immunology. 1998; 95(3):322-30.
PMID: 9824493
PMC: 1364396.
DOI: 10.1046/j.1365-2567.1998.00583.x.